Compare Repligen Corporation Common Stock (RGEN) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Sibanye Stillwater Ltd — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Sibanye Stillwater Ltd trades at $9.63 (market cap $6.99B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Sibanye Stillwater Ltd pays a 8.17% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Sibanye Stillwater Ltd for 51 Days on average.
| RGEN | SBSW | |
|---|---|---|
Market Cap | $11.14B | $6.99B |
Volume | 1,259,263 | 3,905,859 |
Sector | Health | Basic Materials |
52-Week High | $194.57 | $21.12 |
52-Week Low | $102.87 | $8.00 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $11.02B | $7.89B |
Dividend Yield | — | 8.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
SBSW trades at $9.42, down 4.75% on the day, amid a bearish technical signal. The company reported a net loss of $5.17 billion in 2025 despite revenue of $129.68 billion, though profitability is projected to improve significantly in 2026. Analyst consensus is a Moderate Buy with a $14.25 price target. Recent news highlights strong first-half 2026 results, including 54% revenue growth and a surge in operating cash flow, signaling a potential turnaround.
The outlook for SBSW hinges on executing its growth roadmap and capital discipline. Investment opportunities include attractive valuation multiples and projected earnings recovery, but risks persist from commodity price volatility, high debt levels, and operational challenges in South African mining. The stock offers value if management delivers on its 2027-2028 targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
